Zoetis says FDA grants emergency use authorization for Simparica Trio to treat New World screwworm in dogs

Zoetis says the FDA has granted Emergency Use Authorization for Simparica Trio to treat New World screwworm infestations in dogs and puppies.

• Authorization targets myiasis caused by Cochliomyia hominivorax larvae as the parasite threat grows in the US.
• Use is limited to the emergency declaration period; Simparica Trio is not otherwise approved for this indication.